LDN Social Media
Get connected with us on social networks
Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail
Epoch Times
04 November 2022
https://archive.ph/kwlGU#selection-347.0-347.74
Low dose naltrexone (LDN) is among the top treatments for long COVID and vaccine injuries. Doctors treating spike protein injury see it as a syndrome rather than disease, since it is precipitated by dysfunctions in many overlapping pathways. A smaller group of people may not respond to the typical first line treatments or may respond with remaining unresolved conditions.
The first line of treatments particularly focuses on promoting autophagy to clear out the spike protein, the second line of treatment are more directed at reducing its toxicity by resolving the different dysfunctional pathways.
Second-line treatments discussed include:
- Methylene blue (MB) has been recommended by many doctors as a priority second line treatment due to its antiviral, anti-inflammatory, and antioxidizing properties. It carries first line spike injury treatment
- Oxytocin nasal sprays are being used for spike-injured people with brain fog, tinnitus, and a loss of smell. Oxytocin can inhibit mast cell action, promote mitochondrial function, and also increase immune function. It also can reduce inflammation by lowering cortisol
- Nutraceuticals such as vitamins, and adaptogens, are both first- and second-line treatments for spike protein injuries